Aspen Pharmacare Holdings (APNHF) Stock Price & Analysis

16 Followers

APNHF Stock Chart & Stats

$10.17$0.16(1.65%)

At close: Nov 05 4:00 PM EST

Day’s Range: $9.83 - $10.51
52-Week Range: $6.23 - $10.84
Previous Close: $10.01
Volume: N/A
Average Volume (3M): 0
Market Cap: $4.28B
Enterprise Value: $4.22B
Total Cash (Recent Filing): $12.34B
Total Debt (Recent Filing): $36.46B
Price to Earnings (P/E): 28.0
Beta: 0.12
Next Earnings: Mar 11, 2027 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Oct 09, 2026
Dividend Yield: 1.49%

Aspen Pharmacare Holdings News

Aspen Pharmacare Faces Challenges Amid Strategic Growth

Aspen Pharmacare Holdings ( ($APNHF) ) has released its Q4 earnings. Here is a breakdown of the information Aspen Pharmacare Holdings presented to its investors. Aspen Pharmacare Holdings Limited, a

1y agoAPNHF LDZA

Aspen Pharmacare downgraded to Hold from Buy at HSBC

HSBC downgraded Aspen Pharmacare (APNHY) to Hold from Buy with an ZAR 185 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try

1y agoAPNHF APNHY

APNHF FAQ

What was Aspen Pharmacare Holdings’s price range in the past 12 months?

Aspen Pharmacare Holdings lowest stock price was $6.23 and its highest was $10.84 in the past 12 months.

What is Aspen Pharmacare Holdings’s market cap?

Aspen Pharmacare Holdings’s market cap is $4.28B.

When is Aspen Pharmacare Holdings’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Aspen Pharmacare Holdings’s earnings last quarter?

Aspen Pharmacare Holdings released its earnings results on Sep 02, 2026. The company reported $0.161 earnings per share for the quarter.

Is Aspen Pharmacare Holdings overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Aspen Pharmacare Holdings pay dividends?

Aspen Pharmacare Holdings pays a Annually dividend of $0.14 which represents an annual dividend yield of 1.49%. See more information on Aspen Pharmacare Holdings dividends here

What is Aspen Pharmacare Holdings’s EPS estimate?

Aspen Pharmacare Holdings’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aspen Pharmacare Holdings have?

Aspen Pharmacare Holdings has 432,921,450 shares outstanding.

What happened to Aspen Pharmacare Holdings’s price movement after its last earnings report?

Aspen Pharmacare Holdings reported an EPS of $0.161 in its last earnings report. Following the earnings report the stock price went down -7.039%.

Which hedge fund is a major shareholder of Aspen Pharmacare Holdings?

Currently, no hedge funds are holding shares in APNHF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aspen Pharmacare Holdings

Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities are structured into two main divisions: Commercial Pharmaceuticals and Manufacturing. Under its Anaesthetics portfolio, Aspen offers diverse products such as general anesthetics, muscle relaxants, and topical agents. Its Thrombosis brand is dedicated to a variety of injectable anticoagulants, with an emphasis on low molecular weight heparins, Xa inhibitors, and heparin derivatives. Additionally, Aspen provides a range of branded consumer, prescription, and over-the-counter medications through regional brands. These include Circadin (for sleep management), Foxair (for respiratory conditions), Maltofer (an iron supplement), Mybulen (a painkiller), and Zyloric (which controls uric acid production). Beyond its proprietary offerings, the company also manufactures and supplies active pharmaceutical ingredients (APIs) and finished dosage form products to external clients. Founded in 1850, Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings (APNHF) Earnings & Revenues

Historic Earnings Reports

APNHF Company Deck

APNHF Earnings Call

Q4 2026

0:00 / 0:00

Earnings Call SentimentPositive

The call was strongly optimistic. Aspen reported substantial EBITDA, normalized earnings, margin, cash flow, and balance-sheet improvements despite flat group revenue, the loss of a major manufacturing contract, geopolitical impacts, restructuring charges, and a Canadian GLP-1 API issue. Management raised sterile manufacturing guidance and provided expectations for more than 50% normalized headline earnings growth in financial year 2027.

View all APNHF earnings summaries

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	4	2
Technical Analysis	3	4	2
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to APNHF
Company	Price & Change	Follow
BMYBristol-Myers Squibb
RDYDr Reddy's Laboratories
PFEPfizer
BHCBausch Health Companies
SNYSanofi
TEVATeva

Compare APNHF Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft